
Veeda Clinical Research raises $16 million
The Hindu
Veeda Clinical Research has announced that it has raised $16 million in a round led by private equity fund, Sabre Partners. This round also saw participation from HNIs such as Pranab Mody (of JB Chemi
Veeda Clinical Research has announced that it has raised $16 million in a round led by private equity fund, Sabre Partners. This round also saw participation from HNIs such as Pranab Mody (of JB Chemicals), Havells India family office, Nikhil Vora (fFounder of Sixth Sense Ventures) and Arjun Bhartia (of Jubilant). Ajay Tandon, MD, Veeda said, “We will continue to invest in developing our delivery capabilities, to be increasingly relevant to our clients objectives.”More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












